Skyrocketing insulin prices provoke new outrage. Three companies control 99% of insulin production in the US.
The average price of insulin tripled from 2002 to 2013 and Type I diabetics are a captive market. Once again, oligopoly enforced by oligarchy is allowing the public to be gouged. via thehill: Rising insulin costs are drawing outrage from …